Sentences with phrase «in vaccine manufacturing»

Not exact matches

Per Google Finance, Zoetis is «in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.

A manufacturing issue can also cause some vaccine shortages, which has lead to some of the flu shortages in recent years and a shortage in the Hib vaccine in late 2007.

In 1984, she joined Singapore Biotech Pte Ltd. as quality control / technical manager and was involved in hepatitis B vaccine manufacturinIn 1984, she joined Singapore Biotech Pte Ltd. as quality control / technical manager and was involved in hepatitis B vaccine manufacturinin hepatitis B vaccine manufacturing.

Joy: Yeah, but the point is we have the technology now to sequence and manufacture vaccines fairly quickly; and ideally they wouldn't be grown in eggs or whatever, right; because what if it starts as a virus in chickens or something, and we're screwed.

There is no evidence of a long - standing HIV epidemic in Poland, but the Polish vaccine was manufactured at a different time from the batches used in Africa.

The company claims its VLP approach allows it to manufacture a vaccine to match a particular virus strain in about three months.

The authors note that manufacturing strategies may also play a significant role in reduced vaccine effectiveness.

Profectus BioSciences in Tarrytown, New York, which is developing a similar vaccine, needs some $ 2 million to produce it under good manufacturing practice standards, a prerequisite for any human study.

Notably, because no live viruses are used in their manufacture, VLP vaccines do not need to be produced under high - level biocontainment conditions.

CTL119 manufacturing begins with a patient's own T cells, some of which are removed and then reprogrammed in Penn's Clinical Cell and Vaccine Production Facility with a gene transfer technique designed to teach the T cells to target and kill tumor cells.

Still, concerns remain about whether a vaccine can actually be manufactured and approved in time for traditional flu season in the Northern Hemisphere.

The European Union and Australia have also approved the vaccine, and a similar product to be manufactured by GlaxoSmithKline is in the works.

In a press release issued today, the company said it has yet to receive a «seed stock» from the World Health Organization to manufacture the vaccine and that upon receipt of the stock it will require 4 to 6 months to produce the vaccine.

MIT engineers have developed a new type of easily customizable vaccine that can be manufactured in one week, allowing it to be rapidly deployed in response to disease outbreaks.

A new type of easily customizable vaccine can be manufactured in one week, allowing it to be rapidly deployed in response to disease outbreaks, say researchers.

However, Paul Keim, acting chair of the U.S. National Science Advisory Board for Biosecurity (NSABB)-- which recommended that the mutant - flu work should not be published in full — cautions that there are not enough flu vaccines or drugs worldwide, and a rapid pandemic would overwhelm our ability to manufacture more.

They argue that she suffered seizures and developmental delays following a DTP (diptheria, tetanus, pertussis) vaccine manufactured by Wyeth, which she got as a 6 - month - old back in 1992.

The Food and Drug Administration - approved yellow fever vaccine, YF - VAX, is currently unavailable in the US because of manufacturing difficulties, and the alternative yellow fever vaccine, Stamaril, is only available through a limited number of US yellow fever vaccination clinics.

Women and girls in India, where researchers plan to manufacture and distribute the low - cost HPV vaccine.

Dr. Levine directs the Clinical Cell and Vaccine Production Facility (CVPF), which develops, manufactures, and tests novel cell and gene therapies in clinical trials at Penn and collaborating institutions.

The vaccines are easily and rapidly manufactured so that they could potentially be widely available very quickly in the face of an emerging infectious disease.

The Pilot Bioproduction Facility headed by Dr. Kenneth H. Eckels, produced small batches of vaccine candidates that were used for the preclinical studies and is currently manufacturing a vaccine lot for use in initial human clinical studies.

Two studies now suggest a new reason for the problem: The vaccine strain mutates during the manufacturing process in ways that cause mismatches with real circulating flu strains.

Following adverse reactions to the flu vaccine reported in 2010, FDA sent inspectors in June to CSL's manufacturing plant in Melbourne.

GSK, which has invested more than $ 300 million in RTS, S to date, has pledged to keep the price as low as possible — just manufacturing costs plus a small return to be reinvested in development of second - generation malaria vaccines or vaccines against other neglected tropical diseases.

«The Army was able to move so quickly in developing, manufacturing and testing a Zika vaccine because of its extensive experience with this vaccine platform and long standing investments in the understanding and mitigation of flaviviruses, like yellow fever, dating back to the founding of WRAIR,» said Dr. Kayvon Modjarrad, Zika program co-lead and associate director for Emerging Infectious Disease Threats at WRAIR's MHRP.

In WP10, iBET will be involved in activities relating to GMP - directed evaluation of vaccine candidate production processes, production scale - up for vaccine candidates, definition of specifications for pilot - scale production, product stability testing and delivery for GLP toxicology studies, as well as the evaluation of development, manufacturing and finishing documentatioIn WP10, iBET will be involved in activities relating to GMP - directed evaluation of vaccine candidate production processes, production scale - up for vaccine candidates, definition of specifications for pilot - scale production, product stability testing and delivery for GLP toxicology studies, as well as the evaluation of development, manufacturing and finishing documentatioin activities relating to GMP - directed evaluation of vaccine candidate production processes, production scale - up for vaccine candidates, definition of specifications for pilot - scale production, product stability testing and delivery for GLP toxicology studies, as well as the evaluation of development, manufacturing and finishing documentation.

The Pilot Bioproduction Facility at WRAIR manufactured the ZPIV vaccine being used in Phase 1 clinical studies, and the Army recently signed a cooperative research and development agreement to transfer the ZPIV technology to Sanofi Pasteur to explore larger scale manufacturing and advanced development.

In WP10, iBET will be involved in the GMP - directed evaluation of vaccine candidate production processes, production scale - up for vaccine candidates, definition of specifications for pilot - scale production, product stability testing and delivery for GLP toxicology studies, as well as the evaluation of development, manufacturing and finishing documentatioIn WP10, iBET will be involved in the GMP - directed evaluation of vaccine candidate production processes, production scale - up for vaccine candidates, definition of specifications for pilot - scale production, product stability testing and delivery for GLP toxicology studies, as well as the evaluation of development, manufacturing and finishing documentatioin the GMP - directed evaluation of vaccine candidate production processes, production scale - up for vaccine candidates, definition of specifications for pilot - scale production, product stability testing and delivery for GLP toxicology studies, as well as the evaluation of development, manufacturing and finishing documentation.

Cell - based Vaccine Manufacturing There has been increasing interest in moving from egg - based vaccine manufacturing to cell culture - based mVaccine Manufacturing There has been increasing interest in moving from egg - based vaccine manufacturing to cell culture - based mvaccine manufacturing to cell culture - based methods.

Dr. Leo Stamatatos, an immunologist in Fred Hutch's Vaccine and Infectious Disease Division, has received funding from the National Institutes of Health to begin manufacturing an HIV vaccine candidate designed to stimulate the production of broadly neutralizing antibodies and to test the experimental vaccine in human clinical Vaccine and Infectious Disease Division, has received funding from the National Institutes of Health to begin manufacturing an HIV vaccine candidate designed to stimulate the production of broadly neutralizing antibodies and to test the experimental vaccine in human clinical vaccine candidate designed to stimulate the production of broadly neutralizing antibodies and to test the experimental vaccine in human clinical vaccine in human clinical trials.

The use of human embryonic stem cells, as opposed to patient blood, as the starting material for AST - VAC2 provides a scalable system for the production of a large number of vaccine doses in a single lot, reducing manufacturing costs, enabling «off - the - shelf» availability, and ensuring product consistency.

We also provide cell lines for use in the manufacture and testing of vaccines.

The three partner academic institutions will work in tandem to develop the vaccine strains, integrated manufacturing process, and economic models to ensure that ULTRA can achieve costs of less than 15 cents per dose.

He has also participated in technology transfer projects in Brazil and India, where a vaccine formulation center has been constructed to manufacture IDRI - developed adjuvant formulations for clinical trials to evaluate malaria, leishmania, and tuberculosis vaccines.

She is also responsible for IDRI's in - house pilot manufacturing facility that produces cGMP adjuvant formulations for Phase 1 vaccine clinical trials.

He currently serves as principal investigator on a $ 11.9 M contract from the National Institutes of Health (NIH) to develop a thermostable tuberculosis vaccine suitable for distribution in developing countries, involving formulation development, cGMP manufacturing, and clinical testing.

As the sun sets on British research cheat Andrew Wakefield, who in a 1998 paper in The Lancet systematically faked the appearance of a putative link between the MMR vaccine and autism, activists still profiting from the scare he manufactured have followed him further into the cesspit.

In the context of vaccine development and vaccine manufacturing these assays can provide a high value.

Dr. Matyas is working to develop an effective, safe and easily manufactured combination vaccine that could treat heroin addiction while at the same time prevent HIV infection in those receiving the vaccine.

iBET will be involved in activities related with GMP - directed evaluation of vaccine candidate production processes, production scale - up for vaccine candidates, definition of specifications for pilot - scale production, product stability testing and delivery for GLP toxicology studies, and evaluation of development, manufacturing and finishing documentation.

The space was also designed with the public in mind, featuring interactive tour stops throughout the lab space that use technology to underscore IDRI's work in developing vaccines, drugs and diagnostics, as well as large built - in windows to showcase IDRI's specialized facilities, including manufacturing.

Like the multidose influenza vaccines, some multidose meningococcal meningitis vaccines and tetanus toxoid (booster) vaccines (not recommended for children under six years of age) also contain thimerosal as a preservative, in amounts ranging from 12.5 to 25 micrograms per dose.27, 28 As of 2016, some other childhood vaccine preparations, such as the multidose DTaP and the DTaP / Hib combination vaccines, still utilize thimerosal in the manufacturing process.

The vaccine lies in technology titled Student 2.0, which will be easy to manufacture and will be produced in bulk at a fraction of the cost the government spends sending a child to public school.

Zoetis, Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.

The stock ran on the news, prompting VXGN to clarify yesterday that it «retains an option to obtain the exclusive right to manufacture, commercialize, and further develop the HIV vaccine candidates in the U.S., Europe, Japan and other countries that are members of the Organization of Economic Cooperation and Development» but «has no rights or obligations to manufacture or develop the vaccine candidates unless and until it exercises this option.»

In January 2006, VaxGen granted to GSID a worldwide license to research, develop, manufacture, register, use, market, import, offer for sale, and sell its HIV vaccine candidates, including the AIDSVAX B / E vaccine.

Pfizer Animal Health, a business unit of Pfizer Inc, is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic tests.

In some cases, the vaccine can fail — if the vaccination is not stored corrected or if there was a problem in the manufacturing of the vaccine, for instancIn some cases, the vaccine can fail — if the vaccination is not stored corrected or if there was a problem in the manufacturing of the vaccine, for instancin the manufacturing of the vaccine, for instance.

About Pfizer Animal Health Pfizer Animal Health, a business unit of Pfizer Inc., is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic tests.